ClinConnect ClinConnect Logo
Search / Trial NCT07094256

Torque Device Evaluation

Launched by UNIVERSITY OF MINNESOTA · Jul 22, 2025

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new tool called a torque device, which helps doctors during certain heart procedures that study and treat irregular heartbeats in children. Specifically, the trial will check if this device is safe and works well after a child has already had an electrophysiology study or ablation—a procedure where doctors examine the heart’s electrical system and may fix problem areas to improve heart rhythm. Importantly, the usual heart procedure will happen first as decided by the child’s heart doctor, and the study will only begin after everything needed for that procedure is done.

Children and young adults up to 21 years old who are having one of these heart procedures may be eligible to join. If a child takes part, they won’t have to change their treatment plan, and the study will start only after their heart doctor finishes all the necessary tests and treatments. This trial is not yet open for enrollment, but it aims to help improve tools used in treating heart rhythm problems in young patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pediatric patient (≤21 years of age)
  • Undergoing clinically-indicated electrophysiology study and/or ablation procedure
  • Exclusion Criteria:
  • Adult patient (\>21 years)

About University Of Minnesota

The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.

Locations

Minneapolis, Minnesota, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported